Entrepreneur and Bitcoin enthusiast Brandon Quittem discusses the parallels between psychedelics, mycelium networks, Bitcoin, and personal freedom. They explore the evolution of money, the impact of remote work, and the potential for a decentralized future. The conversation touches on historical shifts, individual autonomy, and the transformative power of psychedelics and Bitcoin.

Keith Kurlander has practiced integrative psychotherapy and coaching with individuals, couples and groups for over 15 years. After years of treating highly complex patients, as well as a personal journey of overcoming trauma and mental illness, he turned toward integrative psychiatric practices as a key component to achieving mental health and understanding the healing process. In this episode, he and Paul discuss the core areas to focus on when getting well, the role of psychedelics in healing mental illness and trauma, and the importance of a well-trained therapist and guide.

After a successful career in entrepreneurship and cryptocurrency, Ryan Zurrer turned his attention to the burgeoning psychedelic space. As he continued to learn more via research, attending conferences, and speaking with others, he became concerned about what he considers the “dystopian future” of psychedelic therapies - sterile doctors’ offices, $8000 treatments, synthetic drugs, no community or connection. Determined to help others harness the powerful benefits of plant medicines in traditional settings, he started Vine Ventures, a VC fund focusing on a future in which everyone who wants to access a psychedelic experience can do so safely, legally, and affordably. In this episode, Ryan and Paul discuss the importance of accessibility, Ryan’s criteria for investment, and the differences between a centralized and decentralized approach to therapy and legalization.

When Lynn Marie Morski, M.D., was first introduced to psychedelics at age 35, she had the kind of transformative experience that she knew would greatly help her patients at the VA. But with no legal way to recommend plant medicines, she decided to turn her attention to educating doctors about the benefits of psychedelics. Unsure of where her new venture would take her, Lynn Marie quit her job, started the Plant Medicine podcast, and created the Psychedelic Medicine Association. In this episode, Lynn Marie and Paul discuss bridging the gap between medical practitioners and the advances taking place in the psychedelic research world.

Psychoanalyst, executive coach, author, and Harvard-trained philosopher Peter Carnochan, Ph.D., has spent the last 30 years helping clients unknot problematic feelings, solve challenges, and develop more resilient and expansive modes of living. In this episode, Peter talks with Paul about the many ways philosophy and psychedelic experiences complement each other, the interconnectedness of everything in the universe, the freedom found within boundaries, and the power we have to change our own lives.

Author Brian Muraresku discusses the secret history of the religion with no name, the role of psychedelics in the origins of Western civilization, the significance of Carl Ruck in uncovering the ancient Greeks' use of psychedelics, the transition from beer to wine in religious rituals, the influence of psychedelics on the development of religion and their potential solution to humanity's existential crisis, the profiles and populations drawn to psychedelic experiences, and the author's ongoing search for ancient discoveries and mysteries.

One of the leading advocates in the kratom industry, Mac Haddow spent years working in US government relations, including acting as Chief of Staff at the US Department of Health and Human Services. Today, he is working tirelessly to protect the rights of kratom users and vendors, traveling throughout the US to promote nationwide adoption of the Kratom Consumer Protection Act. In this episode, Mac and Paul discuss the responsible use of kratom—its benefits, risks, and concerns—and also touch on the topic of corruption within the FDA regulatory and approval process.

There’s a growing momentum to legalize therapeutic psychedelics in the United States, with clinics nationwide already offering ketamine therapy, as well as the recent decriminalization of psilocybin in Oregon. What do today’s treatment protocols look like, and what will the future bring? In this episode, Yaron Conforti, CEO and Director of Novamind, talks with Paul Austin, founder of Third Wave, about creating individualized treatment plans, the thousands of clinics we can expect in the next ten years, and democratizing access to psychedelic medicine.

After building and selling a successful software startup, Tim Sae Koo had a psychedelic experience and vision that revealed his true life’s purpose. Today, he devotes himself to 1heart, a home for change makers, creative innovators, and soul seekers who feel called to co-create a collective future as one tribe. In this episode, Tim and Paul reflect on their friendship, and discuss elevating consciousness, building community, and staying out of the matrix.

James Fadiman Ph.D. almost needs no introduction. An early pioneer of psychedelic research, a lifelong proponent of microdosing, and a prolific writer and educator, Jim played a pivotal role in reigniting the conversation around psychedelics in the US and beyond with the publication of his 2011 book, The Psychedelic Explorer’s Guide. In this wide-ranging podcast, Jim chats candidly with Paul Austin about everything from the early years of psychedelic research and the immeasurable benefits of microdosing, to the business of psychedelics, the power of citizen science, and the foundation of our personal identities.